Average Co-Inventor Count = 2.79
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cortech, Inc. (27 from 40 patents)
2. Incyte San Diego Inc. (6 from 8 patents)
3. Ortho-mcneil Pharmaceutical Corp. (4 from 363 patents)
4. Maxia Pharmaceuticals, Inc. (1 from 1 patent)
34 patents:
1. 7226940 - Substituted heterocycles for the treatment of diabetes and other diseases
2. 7196108 - Bicyclic heterocycles for the treatment of diabetes and other diseases
3. 7153875 - Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
4. 7071218 - N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
5. 6974826 - Imidazolidinedione derivatives for the treatment of diabetes and other diseases
6. 6765013 - Thiazolidinedione derivatives for the treatment of diabetes and other diseases
7. 6656911 - Serine protease inhibitors
8. 6656910 - Serine protease inhibitors
9. 6608175 - Serine protease inhibitors
10. 6548638 - Peptoid and nonpeptoid containing &agr;-keto oxadiazoles as serine protease inhibitors
11. 6515003 - Heterocyclic derivatives for the treatment of diabetes and other diseases
12. 6255453 - Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
13. 6159938 - Serine protease inhibitors comprising .alpha.-keto heterocycles
14. 6150334 - Serine protease inhibitors-tripeptoid analogs
15. 6100238 - Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as